ZVRA insider files Form 144 to sell 19,500 shares on 10/10/2025
Rhea-AI Filing Summary
ZEVRA THERAPEUTICS, INC. (ZVRA) filed a Form 144 disclosing a proposed sale of 19,500 common shares by an insider through Morgan Stanley Smith Barney LLC on 10/10/2025. The filing lists an aggregate market value of $210,990 and shows 56,135,091 shares outstanding, implying the sale represents a small fraction of total shares.
The securities were acquired as Restricted Stock Units and the acquisition and planned sale date are both reported as 10/10/2025. No other sales in the prior three months are reported, and the filer affirms they are not in possession of undisclosed material adverse information.
Positive
- Disclosure filed complying with Rule 144 showing proposed sale details
- No prior sales in the past three months reported for the selling person
Negative
- None.
Insights
Insider plans to sell 19,500 RSU-derived shares on 10/10/2025.
The notice shows the insider will sell 19,500 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $210,990. The shares were reported as acquired via Restricted Stock Units on the same date, indicating a contemporaneous vest-and-sell event.
Key dependencies include the accuracy of the reported acquisition date and that no other sales occurred in the prior three months (the form states "Nothing to Report"). Monitor filing-confirmed execution around 10/10/2025 for settlement details and any subsequent Form 4 or amendment within the standard reporting window.